SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-011398
Filing Date
2019-10-03
Accepted
2019-10-03 08:30:36
Documents
3
Period of Report
2019-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cbmg_8k.htm 8-K 32534
2 PRESS RELEASE cbmg_ex991.htm EX-99.1 14355
3 IMAGE cbmg_ex991000.jpg GRAPHIC 8047
  Complete submission text file 0001654954-19-011398.txt   59435
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36498 | Film No.: 191134460
SIC: 2836 Biological Products, (No Diagnostic Substances)